SCHEMBL25812181

SCHEMBL25812181

CC(=O)c1cc2cc(F)cc(Cl)c2[nH]1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 13/20 0.43
KDM4E B2RXH2 1/20 0.37
PDPK1 O15530 1/20 0.37
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
HPGD P15428 1/20 0.37
TSHR P16473 1/20 0.37
NFKB1 P19838 1/20 0.37
APEX1 P27695 1/20 0.37
CYP2C19 P33261 1/20 0.37
HSD17B10 Q99714 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
EIF4A3 P38919 2/20 0.36
SYK P43405 1/20 0.35
FLT3 P36888 2/20 0.33
MEN1 O00255 1/20 0.33
NPC1 O15118 1/20 0.33
POLB P06746 1/20 0.33
RAB9A P51151 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3089645 0.84 HPGD (0.53) HRH4KDM4EPDPK1ALDH1A1LMNA
SCHEMBL29063260 0.83 HRH4 (0.40) HRH4KDM4EPDPK1ALDH1A1LMNA
SCHEMBL17920327 0.83 HRH4 (0.59) HRH4KDM4EALDH1A1LMNAHPGD
SCHEMBL17920264 0.81 HRH4 (0.43) HRH4KDM4EALDH1A1LMNAHPGD
SCHEMBL24019772 0.79 ALOX15 (0.53) HRH4LMNAHPGDEIF4A3MEN1
SCHEMBL3106434 0.79 CDK1 (0.54) HRH4KDM4EALDH1A1LMNAHPGD
SCHEMBL25768433 0.79 ALOX15 (0.53) HRH4MEN1KMT2A
SCHEMBL27337665 0.76 HRH4 (0.59) HRH4KDM4EALDH1A1HPGDAPEX1
SCHEMBL14304329 0.74 HRH4 (0.38) HRH4KDM4EPDPK1ALDH1A1LMNA
SCHEMBL25812180 0.73 EIF4A3 (0.42) HRH4ALDH1A1HPGDHSD17B10EIF4A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230212152-A1 INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF Pardes Biosciences, Inc. 2023-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230212152-A1 INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF CTRL, CTSL, CTSV HRH4 4259/4885KDM4E 3122/4885PDPK1 2742/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.